v3.26.1
Financial Highlights - Schedule of Financial Highlights (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Investment Company, Financial Highlights [Roll Forward]      
Net Asset Value Per Share, Beginning Balance $ 25.26 $ 25.33  
Results of Operations:      
Net Investment Income (Loss) [1] 0.65 0.54  
Net Realized and Unrealized Gain (Loss) on Investments [1] (0.2) 0.09  
Increase (Decrease) in Net Assets Resulting from Operations [1] 0.45 0.63  
Distributions to Shareholders      
Distributions from Net Investment Income (0.63) (0.53)  
Decrease in Net Assets Resulting from Distributions (0.63) (0.53)  
Net Asset Value Per Share, Ending Balance $ 25.08 $ 25.43  
Shares Outstanding, End of Period 18,631,636 10,715,270 18,631,405
Total return [2],[3] 1.79% 2.49%  
Net assets, end of period $ 467,284 [4],[5],[6] $ 272,480 $ 470,638 [7],[8],[9]
Ratio/Supplemental Data      
Weighted-average shares outstanding 18,631,485 10,684,405  
Ratio of net investment income (loss) to average net assets, without expense reimbursement [10] 10.08% 8.80%  
Ratio of net investment income (loss) to average net assets, with expense reimbursement [10] 10.30% 9.30%  
Ratio of total expenses to average net assets without reimbursement [10] 10.57% 11.20%  
Ratio of total expenses to average net assets with reimbursement [10] 10.35% 10.80%  
Asset coverage ratio [11] 2.0685 1.938  
Portfolio turnover rate [2] 2.68% 0.96%  
[1] The per common share data was derived using weighted average shares outstanding.
[2] Not annualized.
[3] Total return is calculated assuming a purchase of shares of common stock at the current net asset value on the first day and a sale at the current net asset value on the last day of the period reported.
[4] All investments domiciled in the United States unless otherwise noted.
[5] The Fund updated certain descriptions of its portfolio companies presented in the consolidated financial statements as of March 31, 2026 to align with the legal issuer name, where applicable. These updates had no impact on the Consolidated Statements of Assets and Liabilities as of March 31, 2026.
[6] Unless otherwise noted, the fair value of investments with respect to securities for which market quotations are not readily available are valued using significant unobservable inputs (See Note 3—Fair Value of Financial Instruments).
[7] All investments domiciled in the United States unless otherwise noted.
[8] The Fund updated certain descriptions of its portfolio companies presented in the consolidated financial statements as of December 31, 2025 to align with the legal issuer name, where applicable. These updates had no impact on the Consolidated Statements of Assets and Liabilities as of December 31, 2025.
[9] Unless otherwise noted, the fair value of investments with respect to securities for which market quotations are not readily available are valued using significant unobservable inputs (See Note 3—Fair Value of Financial Instruments).
[10] Annualized.
[11] Asset coverage ratio is presented as of March 31, 2026 and March 31, 2025, respectively.